We enable innovators

Committed to advancing breakthrough technologies for brain disorders

Founded in 2023, Nexus NeuroTech Ventures has a deep commitment to supporting solutions that hold the greatest promise to help people with neurodegenerative,  neuropsychiatric, and neurodevelopmental disorders, such as Parkinson’s disease, bipolar disorder, and autism spectrum disorder.
See how we invest
Brain ilustration

What sets us apart

We’re building a portfolio to support technology that spans disease diagnosis and management, providing a holistic approach to  brain disorders.  We seek to invest in approaches spanning less invasive to more invasive medical technology-based  treatment interventions, software- and hardware-based diagnostic technology, data platforms supporting clinical trials and clinical care, and tools directed at clinical research and clinical care.

Lightbulb icon

Deep expertise

Jordi, Bill, and Jon bring many years of operational, clinical, engineering, and investment experience across diverse areas of technology directed at healthcare and science.
Target icon

Singular focus

Nexus NeuroTech Ventures is dedicated to advancing technologies targeted directly at or enabling the diagnosis, treatment, or management of brain disorders. Initial disease indications include Parkinson’s disease, bipolar disorder, and autism–along with adjacent conditions from a symptomatic or mechanistic standpoint.
Brain icon

Mission driven

Investments have an intentional goal of bringing impactful solutions to people affected by neurological disorders or psychiatric conditions.

Who we are

The Nexus NeuroTech Ventures team brings together a rare combination of leaders in neurotechnology, clinical neuroscience, and biomedical engineering to direct their expertise at identifying and accelerating technology solutions to address patients’ needs along their journeys.

About us

Want to learn more?

We welcome inquiries from company founders, academic investigators ready to commercialize their innovations, and investors who may wish to partner with us.

Contact us